calendar-Icon

Berlin, Germany

At this year’s European Society for Medical Oncology (ESMO) Congress, we will present the latest transformative data from our oncology portfolio, sharing new data, research and science that reflect our ongoing commitment to reimagining medicine.

Our legacy and leadership in Oncology

Progress in cancer requires being daringly different, with courage to take purpose-led risks and guided by insights that can lead to real change for patients.

ESMO Oncology Leadership VIDEO

 

The latest updates from ESMO 2025

Learn more about Novartis in Oncology

Doctor and patient discussing medical results on an iPad

Oncology

Combining the power of science and empathy to unravel the inner workings of cancer and develop innovative therapies that restore hope to those with cancer and their loved ones.
Medical professional and patient smiling and holding hands

Radioligand Therapy

At Novartis, we are making the promise of next-generation medicines a reality today by leading the development of radioligand therapies (RLTs), a novel approach to cancer care.
A male patient sitting in a doctor’s office

Prostate Cancer

Reimagining medicine to transform prostate cancer treatment
Doctors discussing ultrasound investigation

Breast Cancer

Reimagining medicine to transform treatment in HR+/HER2- breast cancer

Additional resources